Provided by Tiger Trade Technology Pte. Ltd.

Bioxcel Therapeutics Inc.

0.1814
-0.5374-74.76%
Pre-market: 0.1721-0.0093-5.13%04:01 EDT
Volume:58.56M
Turnover:12.57M
Market Cap:5.68M
PE:-0.06
High:0.2299
Open:0.2240
Low:0.1569
Close:0.7188
52wk High:4.29
52wk Low:0.1569
Shares:31.31M
Float Shares:26.89M
Volume Ratio:49.36
T/O Rate:217.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1505
EPS(LYR):-5.7255
ROE:-1766.94%
ROA:-102.43%
PB:-0.05
PE(LYR):-0.03

Loading ...

Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 17, 2024

Major Issues Report

Form 8-K - Current report
Jul 16, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities